Concord Medical Services Holdings (Concord Medical Services Holdings) Days Sales Outstanding : 61.81 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Concord Medical Services Holdings Days Sales Outstanding?

Concord Medical Services Holdings's average Accounts Receivable for the six months ended in Dec. 2023 was $12.00 Mil. Concord Medical Services Holdings's Revenue for the six months ended in Dec. 2023 was $35.42 Mil. Hence, Concord Medical Services Holdings's Days Sales Outstanding for the six months ended in Dec. 2023 was 61.81.

The historical rank and industry rank for Concord Medical Services Holdings's Days Sales Outstanding or its related term are showing as below:

CCM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 69.1 Med: 147.82 Max: 214.75
Current: 69.1

During the past 13 years, Concord Medical Services Holdings's highest Days Sales Outstanding was 214.75. The lowest was 69.10. And the median was 147.82.

CCM's Days Sales Outstanding is ranked worse than
72.84% of 637 companies
in the Healthcare Providers & Services industry
Industry Median: 46.01 vs CCM: 69.10

Concord Medical Services Holdings's Days Sales Outstanding declined from Dec. 2022 (62.15) to Dec. 2023 (61.81).

Concord Medical Services Holdings Days Sales Outstanding Historical Data

The historical data trend for Concord Medical Services Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Medical Services Holdings Days Sales Outstanding Chart

Concord Medical Services Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

149.26

119.57

76.39

104.48

70.27

Concord Medical Services Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															66.50	141.54	62.15	74.38	61.81

Competitive Comparison of Concord Medical Services Holdings's Days Sales Outstanding

For the Medical Care Facilities subindustry, Concord Medical Services Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Concord Medical Services Holdings's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Concord Medical Services Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Concord Medical Services Holdings's Days Sales Outstanding falls into.

Concord Medical Services Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Concord Medical Services Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (18.686	+	10.293)	/	2 )	/	75.264	*	365
=	14.4895					/	75.264	*	365
=	70.27

Concord Medical Services Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (13.7	+	10.293)	/	2 )	/	35.418	*	365 / 2
=	11.9965					/	35.418	*	365 / 2
=	61.81

Concord Medical Services Holdings (NYSE:CCM) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Concord Medical Services Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Concord Medical Services Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Medical Services Holdings (Concord Medical Services Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Medical Services Holdings Ltd (NYSE:CCM) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Room 2701-05 , 36 North Third Ring Road, Tower A, Global Trade Center, Dongcheng District, Beijing, CHN, 100013

Website

https://ir.ccm.cn

Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers and diagnostic imaging centers and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.